Role of HLA-B*58:01-Restricted CD8+ T Cells in HIV-1 Subtype AE Infection.

Area of Science:

• Immunogenetics
• Virology
• T-cell immunology

Background:

• Certain Human Leukocyte Antigen (HLA) alleles, specifically HLA-B*58:01 and HLA-B*57, are known to confer protection against Human Immunodeficiency Virus type 1 (HIV-1) subtypes B and C.
• However, the protective role of these HLA alleles against HIV-1 subtype AE infection remains unclear.
• Previous analyses of HLA-B*58:01-restricted and HLA-B*57-restricted HIV-1-specific CD8+ T-cell responses have been extensive for subtypes B and C, but limited for subtype AE.

Purpose of the Study:

• To investigate the role of HLA-B*58:01-restricted T-cell responses in the context of HIV-1 subtype AE infection.
• To identify specific epitopes recognized by HLA-B*58:01-restricted CD8+ T cells in individuals infected with HIV-1 subtype AE.
• To understand why HLA-B*58:01 does not confer protection against HIV-1 subtype AE infection, unlike its effect on subtypes B and C.

Main Methods:

• Identification of 6 novel HLA-B*58:01-restricted subtype AE epitopes in Vietnamese individuals.
• Analysis of T-cell responses to Gag epitopes restricted by HLA-B*58:01 in the context of subtype AE infection.
• Comparison of T-cell responses and protective effects between different HIV-1 subtypes (B/C vs. AE).

Main Results:

• Six HLA-B*58:01-restricted subtype AE epitopes were identified in Vietnamese individuals.
• HLA-B*58:01-restricted T-cell responses targeting Gag epitopes, which are associated with disease control in subtypes B and C, were found to be non-protective in subtype AE infection.
• A potential loss or reduction in the ability of HLA-B*58:01-restricted T cells specific for certain Gag epitopes was observed in subtype AE infection.

Conclusions:

• The lack of protective effect conferred by HLA-B*58:01 in HIV-1 subtype AE infection may be attributed to the loss or diminished function of specific HLA-B*58:01-restricted T cells targeting certain Gag epitopes.
• These findings highlight the subtype-specific nature of T-cell responses and their impact on HIV-1 disease progression.
• Further research into these epitope-specific T-cell responses could inform the development of more broadly protective HIV-1 vaccines or therapies.